CAMBRIDGE, MA / ACCESSWIRE / January 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been recognized on Fortune’s World’s Most Admired Companies list as part of its “All-Star”

CAMBRIDGE, MA / ACCESSWIRE / January 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been recognized on Fortune’s World’s Most Admired Companies list as part of its “All-Star”

PHILADELPHIA, PA / ACCESSWIRE / January 31, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE American:THQ, THW), (the “Funds” or individually the “Fund”), today announced that the Funds paid the

PHILADELPHIA, PA / ACCESSWIRE / January 31, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI)(NYSE American:THQ, THW), (the “Funds” or individually the “Fund”), today announced that the Funds paid the

TORONTO, ON / ACCESSWIRE / January 31, 2024 / Pelangio Exploration Inc. (TSXV:PX)(OTC PINK:PGXPF) (“Pelangio” or the “Company”) is pleased to provide an update on 2023 activities and the outlook